by Adrian Manz | Aug 3, 2026 | The Doctor's Dose
Micron Shares Rebound as China’s CXMT Plans Major Memory-Chip Expansion Micron Technology shares reversed early losses Monday as the broader semiconductor sector recovered, but the long-term competitive picture for the U.S. memory-chip producer may be growing more...
by Adrian Manz | Aug 2, 2026 | The Doctor's Dose
The Everything Pill? Why GLP-1 Drugs May Be Healthcare’s Biggest Investment Story After AI Artificial intelligence may dominate today’s headlines, but another revolution is quietly transforming healthcare—and it could become one of the biggest long-term...
by Adrian Manz | Aug 1, 2026 | The Doctor's Dose
SpaceX Stock Tumbles as Starship Heat Shield Questions Add to Investor Concerns SpaceX shares continued their dramatic post-IPO slide Friday, falling to another record low as investors grapple with lofty valuation expectations, upcoming insider lockup expirations, and...
by Adrian Manz | Aug 1, 2026 | The Doctor's Dose
Universal Music Stock Plunges 25% as Streaming Growth Slows and AI Concerns Rise Universal Music stock suffered one of its worst trading sessions since becoming a publicly traded company, plunging 25% after disappointing quarterly results raised new concerns about the...
by Adrian Manz | Jul 31, 2026 | The Doctor's Dose
Big Tech AI Investment Tops $1.1 Trillion as Investors Demand Returns Big Tech AI investment has crossed a staggering new threshold as Google, Amazon, Microsoft and Meta commit unprecedented amounts of capital to data centers, advanced chips, cloud infrastructure and...
by Adrian Manz | Jul 30, 2026 | The Doctor's Dose
CoreWeave AI Debt Financing Signals Wall Street Is Demanding More From the AI Boom CoreWeave has completed a $2.6 billion financing backed by its cloud-computing agreement with Anthropic, but the company had to offer investors significantly better terms to get the...
by Adrian Manz | Jul 29, 2026 | The Doctor's Dose
Chip Stocks Tumble as Investors Question the Durability of the AI Boom Global semiconductor and memory stocks suffered another sharp reversal as investors reassessed the sustainability of artificial intelligence spending, rising capital expenditures and aggressive...
by Adrian Manz | Jul 28, 2026 | The Doctor's Dose
Anthropic Claude AI Hacking Incident Raises New Questions About AI Cybersecurity Anthropic Claude AI hacking has become the latest reminder that artificial intelligence is rapidly moving beyond answering questions and into performing autonomous actions in the real...
by Adrian Manz | Jul 26, 2026 | The Doctor's Dose
Stock Market Week Ahead: Fed Decision, Big Tech Earnings and Iran Risk Set Up a Volatile Week The stock market week ahead for July 27 through July 31 brings an unusually concentrated mix of geopolitical risk, Federal Reserve policy, inflation data and market-moving...
by Adrian Manz | Jul 25, 2026 | The Doctor's Dose
AI Hedge Fund Collapse: What Traders Can Learn From the Situational Awareness Meltdown For much of 2026, Leopold Aschenbrenner appeared unstoppable. The former OpenAI researcher turned hedge fund manager reportedly generated returns exceeding 400% during the first...
